Loading clinical trials...
Loading clinical trials...
An Open-Label Phase I Study of the Safety of Perifosine in Combination With Sorafenib for Patients With Advanced Cancers
Conditions
Interventions
Perifosine
Sorafenib
Start Date
October 1, 2006
Primary Completion Date
September 1, 2011
Completion Date
October 1, 2011
Last Updated
February 19, 2014
NCT01247597
NCT06898450
NCT00026884
NCT06658951
NCT06625775
NCT05101070
Lead Sponsor
AEterna Zentaris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions